National Health Investors (NHI) Net Equity Issued and Repurchased (2015 - 2026)

National Health Investors (NHI) has 9 years of Net Equity Issued and Repurchased data on file, last reported at $46.6 million in Q4 2025.

• Quarterly Net Equity Issued and Repurchased fell 67.27% year-over-year to $46.6 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $116.0 million (down 44.17% YoY) and the FY2025 annual result came in at $181.5 million, up 27.49% from the prior year.
• Net Equity Issued and Repurchased rose to $46.6 million in Q4 2025, from $11.4 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $142.4 million in Q4 2024 to a low of -$47000.0 in Q2 2021.
• A 3-year average of $53.1 million and a median of $48.0 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
• Annual changes were most pronounced in 2021 — Net Equity Issued and Repurchased soared 55216.09% — and 2025, when it tumbled 67.27%.
• Tracing NHI's Net Equity Issued and Repurchased over 3 years: stood at -$47000.0 in 2021, then soared by 303065.96% to $142.4 million in 2024, then plunged by 67.27% to $46.6 million in 2025.
• The last three Net Equity Issued and Repurchased figures came in at $46.6 million (Q4 2025), $11.4 million (Q3 2025), and $58.0 million (Q2 2025), per Business Quant data.